SCHEMBL23051872

SCHEMBL23051872

CC(C)C(=O)N[C@@H](COC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 8/20 0.38
▸ CTSS P25774 5/20 0.38
▸ CTSL P07711 3/20 0.38
▸ CTSB P07858 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ GRN P28799 1/20 0.38
▸ SORT1 Q99523 1/20 0.38
▸ TDP1 Q9NUW8 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA7 P43166 1/20 0.36
▸ CAPN1 P07384 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ MMP1 P03956 1/20 0.33
▸ MMP3 P08254 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30030351 0.87 CTSS (0.37) CTSKCTSSCTSLCTSBMAPK1
SCHEMBL30064538 0.84 CTSK (0.44) CTSKCTSSCTSLCTSBCA1
SCHEMBL23051973 0.83 GRN (0.39) CTSKCTSSCTSLCTSBMAPK1
SCHEMBL29750396 0.81 CAD (0.39) CTSKCTSSCTSLCTSBMAPK1
SCHEMBL23051981 0.80 GRN (0.40) CTSKCTSSCTSLCTSBMAPK1
SCHEMBL25453637 0.79 MAPK1 (0.41) CTSKCTSSCTSLCTSBMAPK1
SCHEMBL20571233 0.79 GRN (0.40) CTSKCTSSCTSLCTSBMAPK1
SCHEMBL20571234 0.79 GRN (0.40) CTSKCTSSCTSLCTSBMAPK1
SCHEMBL22262968 0.77 MAPK1 (0.38) CTSKCTSSMAPK1GRNSORT1
SCHEMBL13993198 0.77 GRN (0.43) CTSKMAPK1GRNSORT1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021038426-A1 SUBSTITUTED 1,3-PHENYL HETEROARYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-03-04 — — WO disclosed
Send feedback